Jennison Associates
North America, New York, United States, New York
Description
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs since its founding in 1969.
Investor Profile
Jennison Associates has backed more than 27 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 26 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Post Ipo Equity, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, France.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (26%)
- Post Ipo Equity (22%)
- Series C (15%)
- Series D (11%)
- Series Unknown (7%)
- Private Equity (7%)
- Convertible Note (4%)
- Series F (4%)
- Series E (4%)
Country Focus
- United States (93%)
- Canada (4%)
- France (4%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Genetics
- Biopharma
- Health Diagnostics
- Medical Device
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
